Seattle scientists launch $95M AI biology initiative

A Seattle-based scientific consortium has launched a $95 million initiative applying AI to biology, aiming to accelerate discovery in areas like drug development and genomics. The effort signals growing convergence of AI and life sciences, though specific research targets and institutional partners remain unspecified. This investment underscores the strategic importance of AI-driven biological research, potentially reshaping biotech innovation pipelines.